Transcript
Page 1: Indivo as a Personally-Controlled Research Platform for Chronic Disease Registries Research

Children’s HospitalInformatics Program

HarvardMedical School

INDIVO as a Personally-Controlled Research Platform for Chronic Disease Registries Research

Marc D. Natter, MDProject Manager, CARRAnet Informatics Development CoreFellow, Intelligent Health Lab

Kenneth D. Mandl, MD MPHPI & Director, CARRAnet Informatics Development CoreDirector, Intelligent Health Lab

Intelligent Health Lab & Children’s Hospital Informatics Program, Children’s Hospital BostonCenter for Biomedical Informatics, Harvard Medical School

June 18, 2012

Page 2: Indivo as a Personally-Controlled Research Platform for Chronic Disease Registries Research

Going ‘Retro’:

Translating Research into Improved Care through Registries• Cystic Fibrosis Foundation

– LeRoy Matthews, Warren Warwick, Don Berwick, and others

Left: Gawande A, The Bell Curve. New Yorker Magazine 12/2004Right: http://www.nytimes.com/2009/12/22/health/22cyst.html

Page 3: Indivo as a Personally-Controlled Research Platform for Chronic Disease Registries Research

The Pediatric Oncology Story:Protocol-Based Care, 1981-1991

Sources: 1. Wagner HP, et al. Childhood NHL in Switzerland: incidence and survival of 120 study and 42 non-study patients. Med Pediatr Oncol. 1995 May; 24(5):279-80.2. Sharon Murphy, Pediatric Oncology Group, personal communication

• Patients enrolled on SPOG/POG Protocol: Survival = 76%, N=120• Patients not enrolled in study: Survival = 52%, N = 42

Page 4: Indivo as a Personally-Controlled Research Platform for Chronic Disease Registries Research

NCI; $801.4

NCCDPHP; $707.9

NIA; $378.9

NHLBI; $243.3

NIMH; $202.4

NIDDK; $188.0

NIAMS; $157.1

NIAAA; $139.6

NIAID; $82.0

NINDS; $81.7

NIDA; $29.8

NCBDD; $28.3NCRR; $24.9

NIDCD; $19.3 NIDCR; $16.4 ATSDR; $16.0 NICHD; $12.7 NIEHS; $9.9NIGMS; $9.3

NIOSH; $7.5NCPDCID; $2.1

NIBIB; $1.6NEI; $1.2

NLM; $0.5

FIC; $0.1

NIH & CDC Registry-related Project Funding:FY 2009 active projects by Institute or Center(cumulative since 1992, in millions, FY 2008

CPI-adjusted dollars)

*NIH grants & contracts: FY 1992-2009; CDC grants & contracts: FY 1995-2009

ATSDR: Agency for Toxic Substances & Dis-ease RegistryFIC: Fogarty International CenterNCBBB: Nat'l Center on Birth Defects & De-velopmental DisabilitiesNCCDPDP: Nat'l Center for Chronic Disease Prevention & Health PromotionNCI: National Cancer InstituteNCPDCID: Nat'l Center for Preparedness, Detection, & Control of Infectious DiseasesNCRR: Nat'l Center for Research ResourcesNEI: National Eye InstituteNHLBI: Nat'l Heart, Lung, & Blood InstituteNIA: National Institute on AgingNIAAA: Nat'l Inst on Alcohol Abuse & Alco-holismNIAID: Nat'l Institute of Allergy & Infectious DiseasesNIAMS: Nat'l Institute of Arthritis & Muscu-loskeletal & Skin DiseasesNIBIB: Nat'l Institute of Biomedical Imaging & BioengineeringNICHD: Nat'l Institute of Child Health & Hu-man DevelopmentNIDA: Nat'l Institute on Drug AbuseNIDCD: Nat'l Institute on Deafness & Other Communication DisordersNIDCR: Nat'l Institute of Dental & Craniofa-cial ResearchNIDDK: Nat'l Institute of Diabetes & Digestive & Kidney DisesesNIEHS: Nat'l Institute of Environmental Health SciencesNIGMS: Nat'l Institute of General Medical SciencesNIMH: Nat'l Institute of Mental HealthNINDS: Nat'l Institute of Neurological Disor-ders & StrokeNIOSH: Nat'l Institute for Occupational Safety & HealthNLM: National Library of Medicine

Grand Total: $3.162 Billion

Page 5: Indivo as a Personally-Controlled Research Platform for Chronic Disease Registries Research

Registries and Reasons: Juvenile Idiopathic Arthritis & Risk for Eye Disease

Page 6: Indivo as a Personally-Controlled Research Platform for Chronic Disease Registries Research

CARRAnet Grand Opportunities Grant National Registry

NIAMS RC2AR058934, Sites=56, Current Enrollment>7,000 (Target 20K)

Page 7: Indivo as a Personally-Controlled Research Platform for Chronic Disease Registries Research

CARRAnet: Building ‘Grass Roots’ Access to Subspecialty Research Data

Common Data Set

Enhanced Data Set

Study BStudy A

Study CModular Data Sets,Shared Ontologies

Software as a Service model: server farm provides a SHRINE self-scaling, connected, but private i2b2 ‘cloud’

Data In InForm electronic data capture using standardized forms (for

now) InForm using custom forms (add-on studies) – near future Import study data (raw data files plus data mappings –

spreadsheets, databases, etc) – on the horizon

Page 8: Indivo as a Personally-Controlled Research Platform for Chronic Disease Registries Research

CARRAnet Researcher Portal

Page 9: Indivo as a Personally-Controlled Research Platform for Chronic Disease Registries Research

Children’s HospitalInformatics Program

HarvardMedical School

Still in Search of a System that is:

–Convenient for data input: • Patients and research subjects, not just for investigators• Online consenting for studies

–Manages personal health information for research

–Returns data to research subjects and consented 3rd parties

Page 10: Indivo as a Personally-Controlled Research Platform for Chronic Disease Registries Research

Children’s HospitalInformatics Program

HarvardMedical School

Incorporating Patient-Reported Outcomes(NLM R01 – Mandl, Weitzman, Natter)

10

Page 11: Indivo as a Personally-Controlled Research Platform for Chronic Disease Registries Research

Children’s HospitalInformatics Program

HarvardMedical School

Contact and Personally-identifying Information Management

– Provides a Unique Identifier for all subjects across all CARRA/CARRAnet studies

– Data under site control– Web-based, centrally hosted– Based on INDIVO

• Fine-grained permissions for patient, guardians, family members, care providers, etc

• Subjects can directly enter and update their own data• SMArt, ‘research app’ based approach

Page 12: Indivo as a Personally-Controlled Research Platform for Chronic Disease Registries Research

Children’s HospitalInformatics Program

HarvardMedical School

Use Cases:Juvenile Arthritis + Eye Disease Registries Collaboration

• Inception cohort of 650 children with JIA followed for 5 years

• Technical aims:– Subjects enter and manage contact info– Match subjects across two different

registries without exchanging contact or personally identifying info

– Data exchange between registries– Introduce ‘low-cost’ consent process

Page 13: Indivo as a Personally-Controlled Research Platform for Chronic Disease Registries Research

New Registry Applications,under Development

• M-CM Network: Patient-advocate initiated registry for an especially rare disease

• FDA Reporting App: 3rd party reporting from patient registries

• Ad-hoc Adverse Events Reporting: Post-marketing surveillance studies

• Consensus Treatment Plan Adherence Tool: Collaborative patient-physician views


Top Related